Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Infection and Immunity|March 23, 2006
Chlamydiae modulate gamma interferon, interleukin-1 beta, and tumor necrosis factor alpha receptor expression in HeLa cellsKari Ann Shirey, Joseph M CarlinInfection and Immunity|October 13, 2006
Up-regulation of gamma interferon receptor expression due to Chlamydia-toll-like receptor interaction does not enhance signal transducer and activator of transcription 1 signalingKari Ann Shirey, Joo-Yong Jung, Joseph M CarlinJournal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 19, 2003
Synergistic transcriptional activation of indoleamine dioxygenase by IFN-gamma and tumor necrosis factor-alphaCory M Robinson, Kari Ann Shirey, Joseph M CarlinFrontiers in Immunology|July 20, 2021
Targeting TLR4 Signaling to Blunt Viral-Mediated Acute Lung InjuryKari Ann Shirey, Jorge C G Blanco, Stefanie N VogelJournal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 24, 2006
Upregulation of IFN-gamma receptor expression by proinflammatory cytokines influences IDO activation in epithelial cellsKari Ann Shirey, Joo-Yong Jung, Gregory S Maeder, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2008
Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanismKari Ann Shirey, Leah E Cole, Achsah D Keegan, et al.Innate Immunity|January 18, 2011
Proteinase-activated receptor 2 activation promotes an anti-inflammatory and alternatively activated phenotype in LPS-stimulated murine macrophagesQuan M Nhu, Kari Ann Shirey, Meghan E Pennini, et al.Mbio|March 15, 2018
Serum High-Mobility-Group Box 1 as a Biomarker and a Therapeutic Target during Respiratory Virus InfectionsMira C Patel, Kari Ann Shirey, Marina S Boukhvalova, et al.Vaccine|November 21, 2013
A recombinant anchorless respiratory syncytial virus (RSV) fusion (F) protein/monophosphoryl lipid A (MPL) vaccine protects against RSV-induced replication and lung pathologyJorge C G Blanco, Marina S Boukhvalova, Lioubov M Pletneva, et al.Human Vaccines|July 31, 2010
New insights for development of a safe and protective RSV vaccineJorge C G Blanco, Marina S Boukhvalova, Kari Ann Shirey, et al.Pageof 6